STOCK TITAN

Addus HomeCare CEO Allison sells 98,958 shares

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
4

Rhea-AI Filing Summary

Addus HomeCare Corp Chairman and CEO R. Dirk Allison exercised 98,958 fully vested options on November 9, 2026, at a $37.25 exercise price, acquiring 98,958 common shares; the reported option position following the exercise was 0.

He sold 98,958 common shares that day: weighted-average prices were $122.29 for 37,685 shares, $123.30 for 22,359, and $124.21 for 38,714; another 200 shares sold at $124.81. No Rule 10b5-1 plan is reported.

Insider ALLISON R DIRK
Role Chairman and CEO
Sold 98,958 shs ($12.20M)
Approx. gross sale proceeds $12.20M
Approx. exercise cost $3.69M
Approx. pre-tax spread $8.51M
Share of Position Sold 35.1%
Type Security Shares Price Value
Exercise Employee Stock Option (right to buy) F4 98,958 $0.00 $0.00
Exercise Common Stock 98,958 $37.25 $3.69M
Sale Common Stock F1 37,685 $122.29 $4.61M
Sale Common Stock F2 22,359 $123.30 $2.76M
Sale Common Stock F3 38,714 $124.21 $4.81M
Sale Common Stock 200 $124.81 $25K
Holdings After Transaction: Employee Stock Option (right to buy) — 0 options (Direct); Common Stock — 183,150 shares (Direct)
Holdings Before and After: Employee Stock Option (right to buy), 98,958 to 0 options (Direct); Common Stock, 183,150 to 183,150 shares (Direct)
Other Insiders: 5 other insiders reported open-market sales of this stock in the 30 days up to this filing.
Footnotes (4)
  1. F1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $121.83 to $122.80, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1), (2) and (3) to this Form 4.
  2. F2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $122.85 to $123.80, inclusive.
  3. F3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $123.81 to $124.78, inclusive.
  4. F4. All options are fully vested.
Options exercised 98,958 options November 9, 2026; fully vested
Exercise price $37.25 per share Options exercised November 9, 2026
Sale lot 37,685 shares; $122.29 per share weighted average November 9, 2026; transactions ranged from $121.83 to $122.80, inclusive
Sale lot 22,359 shares; $123.30 per share weighted average November 9, 2026; transactions ranged from $122.85 to $123.80
Sale lot 38,714 shares; $124.21 per share weighted average November 9, 2026; transactions ranged from $123.81 to $124.78
Sale lot 200 shares at $124.81 per share November 9, 2026
Reported option position following exercise 0 options Following the November 9, 2026 exercise
Employee Stock Option (right to buy) financial
"Employee Stock Option (right to buy)"
weighted average price financial
"The price reported in Column 4 is a weighted average price"
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
fully vested financial
"All options are fully vested."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many ADUS shares did Chairman and CEO R. Dirk Allison sell, and at what prices?

R. Dirk Allison sold 98,958 Addus HomeCare common shares across four reported transactions on November 9, 2026. The weighted-average prices were $122.29 for 37,685 shares (transactions at prices ranging from $121.83 to $122.80, inclusive), $123.30 for 22,359 shares (from $122.85 to $123.80), and $124.21 for 38,714 shares (from $123.81 to $124.78); another 200 shares were sold at $124.81. No Rule 10b5-1 plan is reported.

What were the terms of the ADUS option exercise?

On November 9, 2026, Allison exercised 98,958 options to acquire common shares at a $37.25 exercise price. The options were fully vested, and the reported option position following the exercise was 0.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
ALLISON R DIRK

(Last)(First)(Middle)
6303 COWBOYS WAY
SUITE 600

(Street)
FRISCO TEXAS 75034

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Addus HomeCare Corp [ ADUS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
XOfficer (give title below)Other (specify below)
Chairman and CEO
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
11/09/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock11/09/2026M98,958A$37.25282,108D
Common Stock11/09/2026S37,685D$122.29(1)244,423D
Common Stock11/09/2026S22,359D$123.3(2)222,064D
Common Stock11/09/2026S38,714D$124.21(3)183,350D
Common Stock11/09/2026S200D$124.81183,150D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Employee Stock Option (right to buy)$37.2511/09/2026M98,958 (4)03/02/2028Common Stock98,958$00D
Explanation of Responses:
1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $121.83 to $122.80, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1), (2) and (3) to this Form 4.
2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $122.85 to $123.80, inclusive.
3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $123.81 to $124.78, inclusive.
4. All options are fully vested.
/s/ Brian Poff, Attorney-in-Fact for R. Dirk Allison11/10/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading